Medical/Pharmaceuticals

Nuance Pharma Announces Publication of Phase 3 ENHANCE-CHINA Data in the CHEST Journal

Ohtuvayre® (ensifentrine) helped improve lung function in Chinese adult patients in in data published in peer reviewed journal SHANGHAI, April 20, 2026 /PRNewswire/ -- Nuance Pharma ("Nuance" or the "Company") announces that CHEST, the official journal of the American College of Chest Physicians...

2026-04-20 09:00 4268

ACT Genomics Upgrades Clinically Recognized Genomic Test to 101-Gene Panel with 7-Day Turnaround

TAIPEI, April 20, 2026 /PRNewswire/ -- ACT Genomics today announced a significant upgrade to the ACTDrug® series, its next-generation sequencing (NGS) genomic profiling service. The updated panel now covers 101 clinically relevant genes and offers a seven-working-day turnaround time, designed to ...

2026-04-20 09:00 3645

CStone Presented Preclinical Data for Three Novel or Differentiated ADCs at AACR 2026, Including CS5007 (EGFR/HER3)

SUZHOU, China, April 19, 2026 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key disease areas, today announced that the Company pr...

2026-04-20 08:15 4013

Pulnovo Medical Announces Strategic Investment from Medtronic in oversubscribed $100 Million Financing Round

NEW YORK, April 19, 2026 /PRNewswire/ -- Pulnovo Medical, a pioneer in breakthrough therapies for treating Pulmonary Hypertension and Heart Failure, today announced the successful completion of an oversubscribed $100 million strategic financing round with a leading investment by Medtronic, one of...

2026-04-20 08:00 3581

Lundbeck presents new data at AAN 2026 highlighting real-world changes in migraine-related cognitive symptoms after starting VYEPTI® (eptinezumab)

•  The one-year INFUSE study observed patient-reported migraine-related cognitive symptoms at baseline and changes over 6 months in those with at least one prior anti-calcitonin gene-related peptide (anti-CGRP) treatment failure VALBY, Denmark, April 20, 2026 /PRNewswire/ -- H. Lundbeck A/S (Lund...

2026-04-20 01:29 3786

BREAKTHROUGH PRIZE ANNOUNCES 2026 LAUREATES

Six $3 Million Prizes Awarded for Outstanding Discoveries in Life Sciences, Fundamental Physics and Mathematics Gene Therapies for Inherited Blindness, Sickle Cell Disease and Beta-Thalassemia Discovery of Key Genetic Cause of ALS and Frontotemporal Dementia Precision Measurement of Muon's Magn...

2026-04-19 10:38 2845

Ddrops® Supports Children's Healthy Growth at Dripping Colours Montessori Sports Day -- Every Step Toward a Healthier Future

KUALA LUMPUR, Malaysia, April 18, 2026 /PRNewswire/ -- Ddrops® participated in the annual Sports Day hosted by Dripping Colours Montessori on April 18, 2026, reinforcing its commitment to supporting children's healthy growth through active lifestyles and proper ...

2026-04-18 20:00 5696

Antengene Presents Three Novel Programs at AACR 2026, Highlighting Next-Generation ADC and AnTenGager® TCEs

SHANGHAI and HONG KONG, April 18, 2026 /PRNewswire/ -- Antengene Corporation Limited  ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune ...

2026-04-18 08:30 6827

ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds

MUNICH, April 18, 2026 /PRNewswire/ -- The largest real-world study of its kind, presented today at ESCMID Global 2026, shows that maternal vaccination against respiratory syncytial virus (RSV) reduces the risk of hospitalisation in young infants by over 80% when given at least two weeks before b...

2026-04-18 06:01 5544

Lunit to Present Six AI Studies at AACR 2026 Highlighting Advances in Precision Oncology and Real-World Clinical Application

Lunit's AACR 2026 presentations showed how AI-driven biomarkers can improve the efficiency of clinical workflows, uncover spatial features of the tumor microenvironment not captured by conventional methods, and enable integrated analysis to better support treatment decision-making. SEOUL, South ...

2026-04-18 03:00 9675

NYSE Content Update: Defense Tech Company AEVEX to Make Its Public Debut

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, April 17, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begi...

2026-04-17 21:42 9016

The 4th International Conference on Single-Cell and Spatial Omics (TICSSO-4) Successfully Held in Beijing

GUANGZHOU, China  , April 17, 2026 /PRNewswire/ -- From March 28 to 30, 2026, the 4th International Conference on Single-Cell and Spatial Omics was successfully convened in Beijing. The conference was jointly organized by Macau University of Science and Technology, Chongqing Medical University, t...

2026-04-17 20:00 4755

Penetrium Bioscience Unveils Breakthrough Mechanism Solving 137-Year-Old "Seed & Soil" Paradigm, Opening a New Era for Targeted Cancer Therapy

SEOUL, South Korea, April 17, 2026 /PRNewswire/ -- Penetrium Bioscience (KOSDAQ 187660) today announced compelling new scientific evidence demonstrating, for the first time at the cellular level, the underlying mechanism behind the long-standing "Seed & Soil" theory originally proposed by Stephen...

2026-04-17 15:48 5424

World Hemophilia Day 2026 - April 17, 2026 - "Diagnosis: First step to care."

MONTREAL, April 17, 2026 /PRNewswire/ -- On April 17, 2026, the global inherited bleeding disorders community will come together on World Hemophilia Day to advocate for all inherited bleeding disorders. This year's theme of  "Diagnosis: First step to care" highlights the critical importance of di...

2026-04-17 13:00 3110

How IBM Quantum is Enabling Healthcare and Biology Research

In the first ever Q4Bio Challenge, research teams sought to demonstrate scalable quantum algorithms for healthcare, with Algorithmiq's work alongside Cleveland Clinic and IBM earning $2 million Q4Bio prize. * Q4Bio aims to accelerate development of quantum algorithms for healthcare that can ru...

2026-04-17 03:09 3757

DOJ Drops All Charges Against Vasudha

The company welcomes dismissal of the case after maintaining its innocence for more than a year HYDERABAD, India, April 17, 2026 /PRNewswire/ -- Vasudha Pharma Chem Limited ("Vasudha" or the "Company"), a leading pharmaceutical bulk drug and intermediate manufacturing company, announced today th...

2026-04-17 02:32 3940

Ubie Launches Medically Validated Consult LLM as a Trustworthy Online Option for Patients Seeking Health Answers

* The explosion of healthcare-focused LLMs and chatbots has given patients greater access to health information, but the accuracy of results and patient trust are falling short * Built on the company's Symptom Checker, Consult provides a clinically-validated and medically supported option to ...

2026-04-16 21:00 4926

Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity

* Bio-Techne introduces a streamlined brand architecture that organizes its technologies into three focused portfolio brands: R&D Systems™, Bio-Techne Spatial™, and Bio-Techne Diagnostics™. * The new brand structure reflects the scientific journey, connecting early discoveries to translational...

2026-04-16 20:49 4005

Crystal Pharmatech Becomes First Company in Asia-Pacific to Deploy Dedicated MicroED Platform Through Strategic Collaboration with ELDICO Scientific

Advancing industrialized Microcrystal Electron Diffraction (MicroED) capabilities for global drug development SUZHOU, China, April 16, 2026 /PRNewswire/ -- Crystal Pharmatech is a science-driven CRO/CDMO specializing in solid-state research, preformulation studies, and formulation development an...

2026-04-16 20:00 3256

Lunit Surpasses 330+ Sites and 1M Annual Screenings as Breast Imaging AI Moves into Clinical Practice

Lunit highlights enterprise AI adoption and FDA-cleared advancements at SBI 2026 SEOUL, South Korea, April 16, 2026 /PRNewswire/ -- At the Society of Breast Imaging (SBI) Annual Symposium, Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced ...

2026-04-16 20:00 4695
1 ... 23242526272829 ... 649

Week's Top Stories